Aurinia Pharmaceuticals Inc.

NasdaqGM:AUPH Stock Report

Mkt Cap: US$1.3b

Aurinia Pharmaceuticals Financial Health

How is Aurinia Pharmaceuticals's financial position?

Financial Health Score

5/6

Financial Health Score 5/6

  • Short Term Liabilities

  • Long Term Liabilities

  • Debt Level

  • Reducing Debt

  • Stable Cash Runway

  • Forecast Cash Runway

Financial Position Analysis

Short Term Liabilities: AUPH's short term assets ($459.7M) exceed its short term liabilities ($41.8M).

Long Term Liabilities: AUPH's short term assets ($459.7M) exceed its long term liabilities ($23.1M).


Debt to Equity History and Analysis

Debt Level: AUPH is debt free.

Reducing Debt: AUPH has not had any debt for past 5 years.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: AUPH has sufficient cash runway for more than 3 years based on its current free cash flow.

Forecast Cash Runway: Insufficient data to determine if AUPH has enough cash runway if its free cash flow continues to grow or shrink based on historical rates.


Discover healthy companies